For a GLP-1 agonist such as a semaglutide like Ozempic, the lowest dose for starting is usually 0.25 milligrams weekly, says Richard Siegel, MD, codirector of the Diabetes and Lipid Center at Tufts Medical Center
The core of this litigation targets major pharmaceutical companies, Novo Nordisk and Eli Lilly and Co., accusing them of failing to sufficiently warn users about the severe digestive side effects of GLP-1 class drugs, typically prescribed for diabetes management and weight loss
It is very common for patients, especially those with PCOS, to be prescribed both medications
Semaglutide binds to GLP-1 receptors located throughout the body, including the pancreas, brain, and gastrointestinal tract
It might work for you too, but don't be discouraged if it doesn't